文献速递炎症性肠病

炎症性肠病中微生物组变异的排序:一项大型纵向跨洲研究

Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study.
PubMed 文献 · Gut · 2020-06-14

该研究对克罗恩病(CD)303例、溃疡性结肠炎(UC)228例和对照161例的粪便微生物组成(16S rRNA基因测序)进行纵向分析(三个时间点,间隔16周),对疾病活动度、药物、饮食和地理位置等因素的效应大小进行排序。结果显示地理位置解释了大部分微生物群方差,仅次于CD的存在与否,其后依次为手术切除史、饮酒和UC诊断、药物和饮食,而90.3%的组成方差为随机或未解释。作者认为精准医学和微生物群治疗设计需考虑宿主反应异质性、生活方式差异及大量未解释的方差。

要点

  • CD和UC患者微生物多样性降低但变异性增加。
  • 地理位置是微生物群方差的最大贡献因素,仅次于CD的存在与否。
  • 90.3%的微生物组成方差为随机或未解释。

核心结论

  • 地理位置解释了大部分微生物群方差,仅次于CD的存在与否,其后依次为手术切除史、饮酒和UC诊断、药物和饮食,90.3%的组成方差为随机或未解释。
  • 精准医学和微生物群治疗设计需考虑宿主反应异质性、生活方式差异及大量未解释的方差。

研究设计与样本

  • 纵向研究,对CD患者303例、UC患者228例和对照161例的粪便微生物组成进行16S rRNA基因测序,在三个时间点(间隔16周)随访。

主要发现

  • 与对照相比,CD和UC患者微生物多样性降低但变异性增加。
  • 疾病(尤其是CD)与对照之间存在显著的组成差异。
  • 纵向分析显示IBD患者微生物群时间稳定性降低,尤其是疾病活动度变化的患者。
  • 机器学习在建模连续时间点时可将疾病与对照、活动期与非活动期疾病区分开。
  • 地理位置解释了大部分微生物群方差,仅次于CD的存在与否,其后依次为手术切除史、饮酒和UC诊断、药物和饮食,90.3%的组成方差为随机或未解释。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The microbiome contributes to the pathogenesis of inflammatory bowel disease (IBD) but the relative contribution of different lifestyle and environmental factors to the compositional variability of the gut microbiota is unclear. DESIGN: Here, we rank the size effect of disease activity, medications, diet and geographic location of the faecal microbiota composition (16S rRNA gene sequencing) in patients with Crohn's disease (CD; n=303), ulcerative colitis (UC; n = 228) and controls (n=161), followed longitudinally (at three time points with 16 weeks intervals). RESULTS: Reduced microbiota diversity but increased variability was confirmed in CD and UC compared with controls. Significant compositional differences between diseases, particularly CD, and controls were evident. Longitudinal analyses revealed reduced temporal microbiota stability in IBD, particularly in patients with changes in disease activity. Machine learning separated disease from controls, and active from inactive disease, when consecutive time points were modelled. Geographic location accounted for most of the microbiota variance, second to the presence or absence of CD, followed by history of surgical resection, alcohol consumption and UC diagnosis, medications and diet with most (90.3%) of the compositional variance stochastic or unexplained. CONCLUSION: The popular concept of precision medicine and rational design of any therapeutic manipulation of the microbiota will have to contend not only with the heterogeneity of the host response, but also with widely differing lifestyles and with much variance still unaccounted for.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Clooney AG, Eckenberger J, Laserna-Mendieta E, et al. Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study. Gut. 2020. PMID: 32536605. doi:10.1136/gutjnl-2020-321106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。